MedTrace Logo

Application of Citrate Dialysate in Chronic Haemodialysis

NCT01532297 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2014-06-06

No results posted yet for this study

Summary

Study investigating the safety and efficacy of the citrate dialysis solution compared to standard acetate dialysis solution. Use of citrate dialysis solution is not associated with a clinically relevant development of adverse events. It is hypothesized that citrate dialysate may provide a local anticoagulation effect in the dialyser improving removal of uremic toxins.

Conditions

  • Chronic Renal Disease

Interventions

DEVICE

Citrate dialysate (CiDi)

Use during chronic dialysis 3x/week

DEVICE

Standard dialysate (StDi)

Use during chronic dialysis 3x/week

Sponsors & Collaborators

  • Fresenius Medical Care Deutschland GmbH

    lead INDUSTRY

Principal Investigators

  • Michael Schmitz, Dr. · Städt. Klinikum Solingen gemeinnützige GmbH Klinik für Nephrologie und Allgemeine Innere Medizin

  • Olaf Loke, Dr. · Nephrologische Gemeinschaftspraxis

  • Klaus Kalb, Dr. · Märkische Dialysezentren GmbH

  • Bernhard Fach, Dr. · PHV Dialysezentrum

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-04-30
Completion
2013-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01532297 on ClinicalTrials.gov